Acrivon Therapeutics, Inc. (ACRV)
1.86
+0.03
(+1.64%)
USD |
NASDAQ |
Jan 15, 16:00
1.89
+0.03
(+1.61%)
After-Hours: 16:53
Acrivon Therapeutics EPS Diluted (Quarterly): -0.4729 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aclarion, Inc. | -2.930 |
| Vistagen Therapeutics, Inc. | -0.5432 |
| Spero Therapeutics, Inc. | -0.1312 |
| Humacyte, Inc. | -0.1106 |
| PMGC Holdings, Inc. | -19.64 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.23M |
| Total Expenses (Quarterly) | 18.23M |
| Enterprise Value | -68.52M |
| Earnings Yield | -114.5% |
| Normalized Earnings Yield | -114.48 |